Adjuvant therapy of histopathological risk factors of retinoblastoma in
Europe: a survey by the European Retinoblastoma group (EURbG)
- Sabine Dittner-Moormann,
- Madlen Reschke,
- Floor Abbink,
- Isabelle Aerts,
- Hatice Atalay,
- Nadezhda Fedorovna Bobrova,
- Eva Biewald,
- Ines Brecht,
- Shani Caspi,
- Nathalie Cassoux,
- Guilherme Castela,
- Yelena Diarra,
- Catriona Duncan,
- Martin Ebinger,
- David Garcia Aldana,
- Theodora Hadjistilianou,
- Tomáš Kepák,
- Artur Klett,
- Hayyam Kiratli,
- Erika Maka,
- Enrico Opocher,
- Jelena Rascon,
- Katarzyna Pawińska-Wąsikowska,
- Ida Russo,
- Olga Rutynowska-Pronicka,
- Constantino Sábado,
- Sonsoles San Roman Pacheco,
- Karel Svojgr,
- Beate Timmermann,
- Vicktoria Vishnevskia-Dai,
- Angelika Eggert,
- Petra Ritter-Sovinz,
- Nicolaos Bechrakis,
- Helen Jenkinson,
- Annette Moll,
- Francis Munier,
- Maja Beck-Popovic,
- Guillermo Chantada,
- Francois Doz,
- Petra Ketteler
Floor Abbink
Amsterdam UMC, Location VU University Medical Centre
Author ProfileGuilherme Castela
Centro Hospitalar e Universitário de Coimbra
Author ProfileYelena Diarra
University of Duisburg-Essen Faculty of Medicine
Author ProfileCatriona Duncan
Great Ormond Street Hospital For Children NHS Foundation Trust
Author ProfileTheodora Hadjistilianou
Università degli Studi di Siena Facoltà di Medicina e Chirurgia
Author ProfileTomáš Kepák
University Hospital Brno and St. Anna University Hospital/ICRC, Masaryk University
Author ProfileJelena Rascon
Children‘s Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos
Author ProfileKatarzyna Pawińska-Wąsikowska
Department of Pedriatric Oncology and Hematology, Jagiellonian University Medical College
Author ProfileOlga Rutynowska-Pronicka
The Children’s Memorial Health Institute
Author Profile
